IL149330A0 - Method for early prediction of the onset of invasive cancer - Google Patents

Method for early prediction of the onset of invasive cancer

Info

Publication number
IL149330A0
IL149330A0 IL14933000A IL14933000A IL149330A0 IL 149330 A0 IL149330 A0 IL 149330A0 IL 14933000 A IL14933000 A IL 14933000A IL 14933000 A IL14933000 A IL 14933000A IL 149330 A0 IL149330 A0 IL 149330A0
Authority
IL
Israel
Prior art keywords
onset
invasive cancer
early prediction
prediction
early
Prior art date
Application number
IL14933000A
Other languages
English (en)
Original Assignee
Zila Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zila Inc filed Critical Zila Inc
Publication of IL149330A0 publication Critical patent/IL149330A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14933000A 2000-09-26 2000-09-26 Method for early prediction of the onset of invasive cancer IL149330A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/026551 WO2002026266A1 (en) 2000-09-26 2000-09-26 Method for early prediction of the onset of invasive cancer

Publications (1)

Publication Number Publication Date
IL149330A0 true IL149330A0 (en) 2002-11-10

Family

ID=21741811

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14933000A IL149330A0 (en) 2000-09-26 2000-09-26 Method for early prediction of the onset of invasive cancer

Country Status (12)

Country Link
US (1) US7659057B2 (xx)
EP (1) EP1322339A4 (xx)
JP (1) JP2004509637A (xx)
CN (1) CN1399563A (xx)
AU (1) AU776256B2 (xx)
BR (1) BR0015706A (xx)
CA (1) CA2392213A1 (xx)
IL (1) IL149330A0 (xx)
MX (1) MXPA02004428A (xx)
NO (1) NO20022459L (xx)
TW (1) TWI280366B (xx)
WO (1) WO2002026266A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2000237154A1 (en) * 2000-02-28 2001-09-12 Zila, Inc. Method for detecting and killing epithelial cancer cells
US6967015B1 (en) * 2000-07-20 2005-11-22 Zila, Inc. Diagnostic method for detecting dysplastic epithelial tissue
EP1322339A4 (en) 2000-09-26 2004-05-26 Zila Inc METHOD FOR EARLY Predicting the Occurrence of INVASIVE CANCER.
MXPA04002659A (es) * 2001-12-14 2004-06-18 Zila Inc Analisis molecular dirigido por tincion para pronostico y diagnostico de cancer.
BRPI0419122A (pt) * 2004-09-30 2007-12-11 Zila Biotechnology Inc método direcionado por luz para detectar e ajudar uma avaliação adicional de tecido mucoso anormal
US20080044351A1 (en) * 2006-08-15 2008-02-21 Xin Ye Method and procedure to detect oral tissues with high-risk molecular profiles
US20090023138A1 (en) * 2007-07-17 2009-01-22 Zila Biotechnology, Inc. Oral cancer markers and their detection

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321251A (en) * 1979-12-19 1982-03-23 The United States Of America As Represented By The Department Of Health And Human Services Detection of malignant lesions of the oral cavity utilizing toluidine blue rinse
WO1993008847A1 (en) * 1991-10-31 1993-05-13 Ctm Associates, Inc. Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer
US6417003B1 (en) * 1993-01-14 2002-07-09 Zila, Inc. Method and kit for epithelial cancer screening
CA2156920A1 (en) 1993-02-24 1994-09-01 Stephen N. Thibodeau Tumor-specific genomic instability as a prognostic indicator
US5786227A (en) * 1995-06-07 1998-07-28 Biex, Inc. Fluid collection kit and method
NZ322108A (en) 1995-11-13 1999-11-29 Provalis Uk Ltd Diagnostic test apparatus
KR100342342B1 (ko) * 1996-01-16 2002-08-22 자일러, 인코포레이티드 구강암및전암성질환의체내검출을위한방법및조성물
US6194573B1 (en) * 1997-11-13 2001-02-27 Zila, Inc. Process for manufacture of in vivo stain composition
US6086852A (en) * 1997-11-13 2000-07-11 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
US6241683B1 (en) * 1998-02-20 2001-06-05 INSTITUT DE RECHERCHES CLINIQUES DE MONTRéAL (IRCM) Phonospirometry for non-invasive monitoring of respiration
US6405070B1 (en) * 1998-06-16 2002-06-11 Bhaskar Banerjee Detection of cancer using cellular autofluorescence
US6256530B1 (en) * 1998-09-15 2001-07-03 Denvu, L.L.C. Optical instrument and technique for cancer diagnosis using in-vivo fluorescence emission of test tissue
US6649144B1 (en) * 2000-02-28 2003-11-18 Zila, Inc. Method for detecting and killing epithelial cancer cells
AU2000237154A1 (en) * 2000-02-28 2001-09-12 Zila, Inc. Method for detecting and killing epithelial cancer cells
US6376525B1 (en) * 2000-09-15 2002-04-23 Qingzhong Kong Method and composition for treating cancer using cellular organelle crystallizing agents
EP1322339A4 (en) 2000-09-26 2004-05-26 Zila Inc METHOD FOR EARLY Predicting the Occurrence of INVASIVE CANCER.
MXPA04002659A (es) 2001-12-14 2004-06-18 Zila Inc Analisis molecular dirigido por tincion para pronostico y diagnostico de cancer.

Also Published As

Publication number Publication date
NO20022459L (no) 2002-07-05
EP1322339A1 (en) 2003-07-02
CN1399563A (zh) 2003-02-26
US7659057B2 (en) 2010-02-09
AU7987100A (en) 2002-04-08
TWI280366B (en) 2007-05-01
AU776256B2 (en) 2004-09-02
WO2002026266A1 (en) 2002-04-04
EP1322339A4 (en) 2004-05-26
CA2392213A1 (en) 2002-04-04
BR0015706A (pt) 2002-07-16
NO20022459D0 (no) 2002-05-24
US20040235067A1 (en) 2004-11-25
MXPA02004428A (es) 2002-09-02
JP2004509637A (ja) 2004-04-02

Similar Documents

Publication Publication Date Title
EP1066308A4 (en) METHOD FOR SYNTHESIS OF OLIGONUCLEOTIDED
AU2002360766A8 (en) Methods for cancer imaging
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
HK1052183A1 (zh) 製造tetrahydrobenzothiepines的方法
AU2001227966A1 (en) Methods for treating tumors
EP1427743A4 (en) SYNTHESIS OF PYRAZOLOPYRIMIDINES
IL159461A0 (en) Method for enhancing the effectiveness of cancer therapies
AU2001255602A1 (en) Methods for treating bone tumors
HK1073244A1 (en) Immunotherapeutic kit for the treatment of tumors
AU2001297856A1 (en) Method for determining homeostasis of the skin
EP1442062A4 (en) METHOD FOR TREATING CARCINOMA
IL157153A0 (en) System for facilitating selection of investments
IL162511A (en) Method for determining the biological activity of defibrotide
GB2389532C (en) The method of treating cancer
EP1401377A4 (en) CANCER TREATMENT METHODS
AU2002221521A1 (en) Immunotherapeutic combinations for the treatment of tumors
MXPA03007036A (es) Metodo de terapia para cancer.
IL149330A0 (en) Method for early prediction of the onset of invasive cancer
EP1282411A4 (en) ANTICANCER TREATMENT METHOD
EP1380840A4 (en) METHOD OF DIAGNOSING BREAST CANCER
HUP0101947A3 (en) Combination for the treatment of tumors
EP1553965A4 (en) TUMOR TREATMENT METHOD
AU2002326810A1 (en) Method of treating cancerous disease
AU2003294272A8 (en) Methods for diagnosing the presence or stage of cancer
AU2001244025A1 (en) Method for predicting the results of cosmetic surgery